Increasing intracellular iron levels enhances Fenton chemistry and ROS generation, whereas targeted iron delivery systems (e.g., iron oxide nanoparticles) can selectively amplify oxidative stress within tumours (99, 100)
An assessment will identify any nutrient deficiencies that you might already have, or that you could be at high risk of getting once you start taking these medications
Although the benefits of GLP-1 RAs in HF (particularly HFrEF) and CAD remain less definitive, emerging data suggest potential roles in improving PAD and blood pressures, reducing symptoms in HF, and possibly lowering the risk of AF
Timing: The injection can be taken any time of day, with or without food, as long as its on the same day each week
We need to be cautious when comparing results from different trials, as the design can inherently influence outcomes